Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-018-0 | CAS number: 50-21-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Lactic acid is not only a natural molecule found in all higher animals and many microorganisms but also a ubiquitous ingredient used in various kinds of food. Therefore, it is not possible to lower external exposure levels below the minimum required levels for human physiological functions. Nevertheless, given the understanding of lactic acid production under human physiological conditions, there is no reproductive/developmental toxicity concern of lactic acid.
Lactic acid is a natural metabolite found in humans and animals as it can be endogenously produced from metabolic pathways such as glycogen breakdown, glycolysis and amino acid metabolism. Normal human blood contains 8–17 mg lactic acid/100 mL plasma, and the concentration of lactate in normal human skin is three times or more of that in the blood due to glycolytic enzymes, which actively convert glucose to lactic acid in the epidermis. Furthermore, lactic acid bacteria, which produce lactic acid as one of their major fermented products, are abundantly found in humans, including breast milk and vaginal cavity, and are considered as probiotic bacteria. Infants can be exposed to lactic acid baccilli during breastfeeding. Lactic acid bacteria are known to be beneficial in preserving healthy vaginal functions such as maintenance of acidic vaginal pH and the prevention of infections.
In accordance with Section 1 of REACH Annex XI, reproductive/developmental toxicity study does not need to be conducted. Given the existing data and taking a weight-of-evidence approach, there is no reproductive/developmental toxicity concern of D(-)-lactic acid.
Link to relevant study records
- Endpoint:
- extended one-generation reproductive toxicity - basic test design (Cohorts 1A, and 1B without extension)
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Reproductive effects observed:
- not specified
- Endpoint:
- screening for reproductive / developmental toxicity
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Referenceopen allclose all
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No reproductive/developmental toxicity data is available for the target substance lactic acid. Lactic acid is a natural metabolite found in humans and animals as it is endogenously produced from metabolic pathways such as glycogen breakdown, glycolysis and amino acid metabolism. Normal human blood contains 8-17 mg lactic acid/100 mL plasma, and the concentration of lactate in normal human skin is three times or more of that in the blood due to glycolytic enzymes, which actively convert glucose to lactic acid in the epidermis. Lactic acid has been detected in blood but also in several other body fluids and tissues. Concentrations of lactic acid increase significantly during intense exercise. At rest, blood concentrations have been reported of 1-1.5 mMol/L (90.1-135.12 mg/L), which can increase up to 10 mMol/L (900.8 mg/L) during exercise. External human exposure to lactic acid can occur via its natural presence in food, for example in fruit, vegetables, sour milk products, and fermented products such as sauerkraut, yogurt and beer. Based on the available information on concentrations of lactic acid in some of these products, an estimate of the daily consumption of lactic acid due to its natural presence in food was made using the ‘FAO/WHO standard European diet’. A (minimum) daily intake of 1.175 g/person/day was calculated using the available information. Another source of external exposure is its use as food additive; as such it is authorized in Europe (E270) and the United States (generally recognized as safe = GRAS). A daily intake of 1.65-2.76 g/person/day was estimated using the “Per Capita times 10” method, based on the amount of lactic acid placed on the market (EU and USA) as a food additive by Purac (please refer to IUCLID section 7.1.1, Sterenborg 2007 for detailed information). Due to its role as a common and natural food ingredient, and ubiquitous metabolic product/substrate in mammals with proven low toxicity, it can safely be concluded that lactic acid does not contribute to any systemic effects. Lactic acid is a major and essential species in mammalian primary metabolism, and a ubiquitous ingredient in all kinds of food. There is no way of lowering exposure below minimum required levels or normal (or even abnormal) internal levels. Furthermore, lactic acid bacteria, which produce lactic acid as their major fermented product, are abundantly found in humans, including breast milk and vaginal cavity, and are considered as probiotic bacteria. Infants can be exposed to lactic acid bacteria during breastfeeding. Lactic acid bacteria are known to be beneficial in preserving healthy vaginal functions such as maintenance of acidic vaginal pH and the prevention of infections. These observations are common textbook knowledge and hence can be considered as adequately and reliably documented, fulfilling the criteria of REACH Annex XI, section 1.1. Supporting evidence that lactic acid has no potential to induce any reproductive/developmental toxicity is derived from a sub-chronic repeated dose toxicity study conducted with calcium lactate. No adverse effects on reproductive organs were described. Calcium lactate is a suitable read-across partner as the substance either dissociate or hydrolyse, thereby liberating lactic acid/lactate. In summary, reproductive/developmental toxicity is not a relevant endpoint for such a substance since there is no way of lowering exposure below minimum required levels or normal (or even abnormal) internal levels. Thus, in accordance with REACH annex XI, section 1.1 it is scientifically not justified to conduct a developmental study in rats with the target substance lactic acid.
The lack of reproductive/developmental toxicity concern of lactic acid is also supported by animal data on foetal development or sex ratio (see IUCLID sections 7.8.1 and 7.8.2).
Effects on developmental toxicity
Description of key information
Lactic acid is a major and essential species in mammalian primary metabolism, and a ubiquitous ingredient in all kinds of food. Developmental toxicity is not a relevant endpoint for such a substance since there is no way of lowering exposure below minimum required levels or normal (or even abnormal) internal levels. In accordance with section 1.1 of REACH Annex XI, reproductive/developmental toxicity studies do not need to be conducted as scientifically not justified.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Species:
- rabbit
- Endpoint:
- developmental toxicity
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Species:
- rat
- Abnormalities:
- not specified
- Developmental effects observed:
- not specified
Referenceopen allclose all
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Lactic acid is a major and essential species in mammalian primary metabolism, and a ubiquitous ingredient in all kinds of food. Developmental toxicity is not a relevant endpoint for such a substance since there is no way of lowering exposure below minimum required levels or normal (or even abnormal) internal levels.
Supporting information was derived from a developmental toxicity study, in which pregnant mice were treated with 570 mg/kg bw during gestation days 6-15. No adverse signs of developmental/reproductive toxicity were observed. In summary and in accordance with REACH annex XI, section 1.1 it is scientifically not justified to conduct a developmental study in rats/rabbits with the target substance lactic acid and classification for reproductive/developmental toxicity is not warranted.
Justification for classification or non-classification
In accordance with Section 1 of REACH Annex XI, a reproductive/developmental toxicity study in rats/rabbits does not need to be conducted. Given the existing data and taking a weight-of-evidence approach, there is no reproductive/developmental toxicity concern of lactic acid. Therefore, no classification for developmental/reproductive toxicity is warranted for lactic acid.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)